These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19451796)

  • 21. Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.
    Tenforde MW; Mokomane M; Leeme T; Patel RKK; Lekwape N; Ramodimoosi C; Dube B; Williams EA; Mokobela KO; Tawanana E; Pilatwe T; Hurt WJ; Mitchell H; Banda DL; Stone H; Molefi M; Mokgacha K; Phillips H; Mullan PC; Steenhoff AP; Mashalla Y; Mine M; Jarvis JN
    Clin Infect Dis; 2017 Sep; 65(5):779-786. PubMed ID: 28505328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.
    Vibhagool A; Sungkanuparph S; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C; Ingsathit A
    Clin Infect Dis; 2003 May; 36(10):1329-31. PubMed ID: 12746781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
    Park BJ; Wannemuehler KA; Marston BJ; Govender N; Pappas PG; Chiller TM
    AIDS; 2009 Feb; 23(4):525-30. PubMed ID: 19182676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cryptococcal neuromeningitidis in HIV-infected patients in Bangui, in the era of antiretroviral treatment].
    Gbangba-Ngai E; Fikouma V; Mossoro-Kpinde CD; Tekpa G; Ouavene JO; Yangba Mongba DS; Mbelesso P
    Bull Soc Pathol Exot; 2014 May; 107(2):106-9. PubMed ID: 24570116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy.
    Tan IL; McArthur JC
    Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana.
    Tenforde MW; Milton T; Rulaganyang I; Muthoga C; Tawe L; Chiller T; Greene G; Jordan A; Williams CG; Owen L; Leeme TB; Boose A; Ngidi J; Mine M; Jarvis JN
    Clin Infect Dis; 2021 May; 72(9):1635-1638. PubMed ID: 32604411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptococcal meningitis in AIDS patients: an emerging opportunistic infection in Senegal.
    Hovette P; Soko TO; Raphenon G; Camara P; Burgel PR; Garraud O
    Trans R Soc Trop Med Hyg; 1999; 93(4):368. PubMed ID: 10674078
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.
    Bhati R; Pramendra S; Sejoo B; Kumar D; Bohra GK; Meena DS; Verma D; Midha NK
    Curr HIV Res; 2021; 19(1):35-39. PubMed ID: 32860359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome].
    Braicks O; Anneken K; Reichelt D; Schäbitz WR; Dziewas R; Evers S; Husstedt IW
    Nervenarzt; 2011 Oct; 82(10):1290-5. PubMed ID: 21567297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.
    Kambugu A; Meya DB; Rhein J; O'Brien M; Janoff EN; Ronald AR; Kamya MR; Mayanja-Kizza H; Sande MA; Bohjanen PR; Boulware DR
    Clin Infect Dis; 2008 Jun; 46(11):1694-701. PubMed ID: 18433339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.
    Jarvis JN; Lawn SD; Vogt M; Bangani N; Wood R; Harrison TS
    Clin Infect Dis; 2009 Apr; 48(7):856-62. PubMed ID: 19222372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count.
    De Beaudrap P; Boullé C; Lewden C; Gabillard D; Nacro B; Diagbouga S; Fassinou P; Hien H; Laurent C; Msellati P;
    Pediatr Infect Dis J; 2013 Apr; 32(4):354-60. PubMed ID: 23099424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
    Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
    Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis.
    Bicanic T; Wood R; Bekker LG; Darder M; Meintjes G; Harrison TS
    Lancet Infect Dis; 2005 Sep; 5(9):530-1. PubMed ID: 16122672
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012.
    McKenney J; Smith RM; Chiller TM; Detels R; French A; Margolick J; Klausner JD;
    MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(27):585-7. PubMed ID: 25006824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy.
    Martínez E; García-Viejo MA; Marcos MA; Pérez-Cuevas JB; Blanco JL; Mallolas J; Miró JM; Gatell JM
    AIDS; 2000 Nov; 14(16):2615-7. PubMed ID: 11101078
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
    Micol R; Lortholary O; Sar B; Laureillard D; Ngeth C; Dousset JP; Chanroeun H; Ferradini L; Guerin PJ; Dromer F; Fontanet A
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):555-9. PubMed ID: 17577124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.
    Wake RM; Britz E; Sriruttan C; Rukasha I; Omar T; Spencer DC; Nel JS; Mashamaite S; Adelekan A; Chiller TM; Jarvis JN; Harrison TS; Govender NP
    Clin Infect Dis; 2018 Feb; 66(5):686-692. PubMed ID: 29028998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective study of AIDS-associated cryptomeningitis.
    Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.